Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.
暂无分享,去创建一个
Roger Le Grand | Céline Terrat | Bernard Verrier | Thierry Delair | T. Delair | B. Verrier | A. Ganée | S. Munier | Y. Ataman-Onal | R. Le Grand | F. Martinon | Pierre-Yves Durand | C. Terrat | P. Durand | N. Battail | M. Charles | Yasemin Ataman-Onal | Séverine Munier | Arnaud Ganée | Nicole Battail | Frédéric Martinon | Marie-Hélène Charles | Céline Terrat
[1] T. Delair,et al. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. , 2005, Colloids and surfaces. B, Biointerfaces.
[2] H. Merkle,et al. Immobilisation of GM-CSF onto particulate vaccine carrier systems. , 2004, International journal of pharmaceutics.
[3] B. Gander,et al. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[4] Hans P Merkle,et al. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.
[5] D. O'hagan,et al. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. , 1994, Immunology.
[6] J. Nah,et al. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. , 2000, International journal of pharmaceutics.
[7] Y. Ohya,et al. Preparation of poly(L-lactide)-based microspheres having a cationic or anionic surface using biodegradable surfactants. , 2002, Biomacromolecules.
[8] A. Almeida,et al. Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l‐lactic acid) Microspheres in Rats, Rabbits and Guinea‐pigs , 1993, The Journal of pharmacy and pharmacology.
[9] R. Mumper,et al. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. , 2002, International journal of pharmaceutics.
[10] M. Pizza,et al. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. , 2004, Journal of pharmaceutical sciences.
[11] Wenlei Jiang,et al. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.
[12] M. Hedley,et al. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses , 1998, Nature Medicine.
[13] Manmohan J. Singh,et al. Controlled Delivery of Diphtheria Toxoid Using Biodegradable Poly(D,L-Lactide) Microcapsules , 1991, Pharmaceutical Research.
[14] D. Rahman,et al. Biodegradable microparticles as controlled release antigen delivery systems. , 1991, Immunology.
[15] T. Delair,et al. Poly(d,l-lactic acid) and chitosan complexes: interactions with plasmid DNA , 2005 .
[16] G. Ott,et al. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[17] G. Altavilla,et al. Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application. , 2004, Vaccine.
[18] J. Clements,et al. Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response. , 2001, Vaccine.
[19] D. Sesardic,et al. European union regulatory developments for new vaccine adjuvants and delivery systems. , 2004, Vaccine.
[20] P. Travers,et al. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. , 1998, Journal of immunology.
[21] Gupta,et al. Aluminum compounds as vaccine adjuvants. , 1998, Advanced drug delivery reviews.
[22] H. Okada,et al. Biodegradable microspheres in drug delivery. , 1995, Critical reviews in therapeutic drug carrier systems.
[23] Russell J Mumper,et al. Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. , 2004, Vaccine.
[24] B. Verrier,et al. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification. , 1993, Protein expression and purification.
[25] E. Hundt,et al. Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice , 2001, Pharmaceutical Research.
[26] S. Davis,et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[27] J. Ulmer,et al. Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines , 2001, Journal of Virology.
[28] T. Delair,et al. One-step cationic poly(D,L-lactic acid) particle synthesis by diafiltration and interactions with plasmid DNA , 2005 .
[29] Manmohan J. Singh,et al. Charged polylactide co-glycolide microparticles as antigen delivery systems , 2004, Expert opinion on biological therapy.
[30] J. Mcghee,et al. Biodegradable microspheres as a vaccine delivery system. , 1991, Molecular immunology.
[31] J. Ulmer,et al. Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles , 2003, Journal of Virology.